Navigation Links
OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
Date:2/12/2013

ability, tumor response rates and the effect of therapy on Hsp27 levels and circulating tumor cells.

Borealis-2 will be conducted at approximately 30 sites in the U.S. and is being sponsored by the Hoosier Oncology Group. Dr. Noah Hahn from the Indiana University Simon Cancer Center, Dr. Toni Choueiri from the Dana-Farber Cancer Institute and Dr. Jonathan Rosenberg from Memorial Sloan-Kettering Cancer Center will serve as the primary investigators on the study.

ABOUT ORCA
The "ORCA" (Overcoming Resistance in CAncer) program encompasses the on-going studies of OGX-427 aiming to demonstrate that inhibition of Hsp27 can lead to improved prognosis and treatment outcomes for cancer patients. Phase 2 clinical trials are underway in prostate and bladder cancers, with additional studies expected to initiate this year. For more information on OGX-427 and ORCA, please visit www.oncogenex.com.

ABOUT ONCOGENEX
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NYSE:  TEVA) have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. OGX-427 is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development. More information is available at
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
2. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013   National Community Pharmacists Association ... RPh, MBA issued the following statement today regarding a ... Part D "preferred pharmacy" drug plans , which ... plan,s lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Today at ... Christine Ginocchio discussed Specific ... for rapid identification of microorganisms producing bloodstream infection. ... Chief of the Division of Infectious Disease Diagnostics ... largest not-for-profit, non-sectarian health system. (Photo: ...
(Date:5/20/2013)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... 38 th Annual Deutsche Bank Health Care Conference ... 2013, at 1:30 p.m. EDT. (Logo: ... listen to the live discussion via the internet link ... http://www.media-server.com/m/p/f7bj3q84 . A recorded replay of the discussion ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 2011 Nopras Technologies, Inc., a ... services for organizations in the Pharmaceutical, Biotechnology, Medical ... January 10th, 2011 that it has achieved ... well documented procedures and processes, its proactive response, ...
... 10, 2011 Drawing attention to its TemporalScanner™ Temporal ... "game-time temperature" for national radio broadcasts of NFL games ... The "Exergen Game Time Temperature" promotion is the only ... Night Football and Monday Night Football regular season games, ...
Cached Medicine Technology:Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification 2Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games 2
(Date:5/20/2013)... 20, 2013 When a shopper decides to ... part of the process. Much of the stress and concern ... not knowing what to expect. Best Mattress Online, a ... use to ensure their purchase proves smooth. , In the ... Mattress Online ”, readers find helpful tips divided into two ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to ... symptoms, as if not treated, it may involve the ureter ... a urinary tract infection in itself is not life threatening, ... called pyelonephritis. Women seem to have many more urinary tract ... percentage as women after the age of fifty. , ...
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... has just been released to the public creating ... to gain access to this elite business training. ... the course as well as an exclusive bonus. ... known for providing elite business training to individuals ...
(Date:5/20/2013)... 20, 2013 Leading facial plastic surgeon and ... as a “Top Doc” in the field of Otolaryngology in ... , The Palm Beacher magazine, one of Palm Beach County’s ... in the May/June 2013 issue, including 70 of the very ... dining, events, things to do, health and fitness, people to ...
(Date:5/20/2013)... The Environmental Design Research ... of continuing education credit opportunities for design professionals, ... Architects Continuing Education System (AIA/CES), the Landscape Architecture ... Design Continuing Education Council (IDCEC). EDRA44Providence ... at the Omni Providence Hotel in Providence, Rhode ...
Breaking Medicine News(10 mins):Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2
... Consortium, a group of researchers, clinicians and families dedicated ... autism, announced today that it has completed the first ... Autism Gene Discovery Project and has released the reference ... the world can use. The scan was conducted ...
... (Chicago, IL, October 22, 2007) Hospitalized patients who ... the use of hypnotherapy than patients using other smoking ... the 73rd annual international scientific assembly of the American ... who participated in one hypnotherapy session were more likely ...
... Bayer Consumer Care announces,the availability of the ... Sinus), combining a long-lasting nasal decongestant with the,pain-relieving ... from,multiple sinus and pain symptoms. The combination ... in a recent survey of adults who suffer ...
... upon its impressive past,successes, the Midwest Orthopaedic Research ... will propel it forward in the coming decade. ... product,innovation, will solidify MORF as a world-class research ... MORF will be restructuring the board of directors,and ...
... Mind,s emotion centers less controlled when weary, MRI study shows ... little testy after a bad night,s sleep? Scientists may ... lack of sleep causes the brain,s emotional centers to dramatically ... lobe -- a brain region that normally keeps emotions under ...
... annual awards recognize technology innovation for healthcare., ... Healthcare Users Group (MS-HUG) and Microsoft Corp. today,announced ... Healthcare Innovation,Awards. The contest, open to any healthcare ... improve the quality and delivery of,healthcare. (Logo: ...
Cached Medicine News:Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 3Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 4Health News:Hypnosis for smoking cessation sees strong results 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 3Health News:Sleepless Nights Make for Grumpier Brains 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 3
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits all seven ... channel tip cone modules. ...
... , The new Finnpipette Novus is so user-friendly that ... few minutes. With the intuitive instantly familiar menu and ... functions you need quickly and easily. The large, clear ... names of all functions. The easily accessible two ...
Medicine Products: